Pasithea therapeutics corp.KTTA.US Overview

US StockHealthcare

(No presentation for KTTA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

KTTA Overall Performance

KTTA AI Analysis & Strategy

KTTA Recent Performance

-1.21%

Pasithea therapeutics corp.

0.81%

Avg of Sector

-1.14%

S&P500

KTTA PowerScanner

KTTA Key Information

KTTA Valuation Metrics

KTTA Earnings Table

KTTA Profile

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.